Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography

Back

ESC Professional Premium Access

Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography

Session: Innovations in public health and health economics (1)

Topic: Public Health

Speaker: Doctor J. Chung (Seoul, KR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Doctor Jaehoon Chung

National Medical Center, Seoul (Korea (Republic of))

0 follower

4 more presentations in this session

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.

Speaker: Professor A. Goette (Paderborn, DE)

Quantity and quality of shared decision making incorporation across major international cardiology guidelines

Speaker: Doctor B. MacDonald (Vancouver, CA)

Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries

Speaker: Doctor M. Walli-Attaei (Oxford, GB)

Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study

Speaker: Mr A. Holt (Copenhagen, DK) Miss J. Liang (Auckland, NZ)

Access the full session

Innovations in public health and health economics (1)

Speakers: Doctor J. Chung, Professor A. Goette, Doctor B. MacDonald, Doctor M. Walli-Attaei, Mr A. Holt...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Influence of socioeconomic status on the presence of obstructive coronary artery disease and cardiovascular outcomes in patients undergoing invasive coronary angiography

About the speaker

Doctor Jaehoon Chung

4 more presentations in this session

An economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillation from a German healthcare service payer perspective.

Quantity and quality of shared decision making incorporation across major international cardiology guidelines

Variations in the costs of atrial fibrillation: a longitudinal study across 27 European and Central Asian countries

Cardiovascular risk prediction in a New Zealand cohort of patients with known cardiovascular disease - a regional individual patient-level data linkage study

Access the full session

Innovations in public health and health economics (1)

About the event

ESC Congress 2023

ESC 365 is supported by